Bluefin Capital Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50,000
Closed -$1.25K 173
2023
Q4
$1.25K Hold
50,000
﹤0.01% 227
2023
Q3
$3.75K Hold
50,000
﹤0.01% 158
2023
Q2
$2.13K Buy
+50,000
New +$1.02M ﹤0.01% 159
2023
Q1
Sell
-199,000
Closed -$4.33M 190
2022
Q4
$23.7K Buy
199,000
+50,000
+34% +$1.05M ﹤0.01% 313
2022
Q3
$8K Hold
149,000
﹤0.01% 472
2022
Q2
$93K Sell
149,000
-151,800
-50% -$4.04M 0.01% 368
2022
Q1
$216K Buy
300,800
+149,000
+98% +$5.63M 0.02% 314
2021
Q4
$398K Buy
+151,800
New +$10.5M 0.03% 386

Other funds holding CYRX

Bluefin Capital Management's CYRX Position: Q1 2024 in Review

Bluefin Capital Management sold out of CryoPort (CYRX) in Q1 2024, closing a stake of 1,474 shares — an estimated $23.5K sold.

Bluefin Capital Management first reported a position in CYRX in Q1 2022 and held it in 6 quarters. The position peaked at $2.09M in Q4 2022. 150 funds tracked by Wall St. Rank hold CYRX as of Q1 2024.

  • Bluefin Capital Management reported no remaining CryoPort position as of Q1 2024 after selling out during the quarter.
  • Bluefin Capital Management sold 1,474 CryoPort shares in Q1 2024, an estimated $23.5K.
  • Bluefin Capital Management first reported a position in CryoPort in Q1 2022 and held it in 6 quarters.
  • Bluefin Capital Management's CryoPort position peaked at $2.09M in Q4 2022.
  • 150 funds tracked by Wall St. Rank held CryoPort as of Q1 2024.

Based on Bluefin Capital Management's 13F filing for Q1 2024, filed 15 May 2024.